Key Summary
- The UK government has announced a £20 million investment to expand prostate cancer research.
- It specifically targets long-standing screening and treatment inequalities for Black men.
- Alongside trial expansions, the government is planning England’s first targeted screening programme and broadening access to advanced, less invasive focal therapies.
The UK government has unveiled a £20 million fund aimed at transforming prostate cancer research and treatment, with a specific focus on increasing clinical trial access for Black men, who are at high risk.
According to official announcements, the funding will directly expand the landmark TRANSFORM study.
Jointly funded by Prostate Cancer UK and the National Institute for Health and Care Research (NIHR), the trial is testing the most effective ways to detect prostate cancer early, maximise survival rates, and minimise the harms of unnecessary, invasive treatments.
For the first time, the study will be scaled up so that every eligible Black man in the country will be invited to take part.
To ensure the recruitment drive successfully reaches all communities, TRANSFORM investigators are teaming up with Prostate Cancer UK to launch localised community engagement campaigns.
Highlighting the political weight behind the initiative, the deputy prime minister and the health secretary are hosting a roundtable with local community leaders this week to discuss how to best support and encourage participation in the research.
Alongside this, the government has accepted a recommendation from the independent UK National Screening Committee (UK NSC) to introduce England’s first targeted prostate cancer screening programme.
Deputy prime minister, David Lammy, said: “Helping more Black men take part in this research is about saving lives, closing deadly inequalities and making sure we understand what works best for those most at risk.”
